191868-14-1
中文名称
N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate
英文名称
N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate
CAS
191868-14-1
分子式
C31H36F3N7O5
分子量
643.67
MOL 文件
191868-14-1.mol
更新日期
2024/12/16 11:45:50
191868-14-1 结构式
基本信息
中文别名
化合物BIBO3304 TFA 英文别名
BIBO 3304BIBO3304 TFA
BIBO 3304 (BIBO3304)
BIBO 3304 trifluoroacetate
N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate
常见问题列表
生物活性
BIBO3304 TFA 是一种高效的、具有口服活性的、选择性的神经肽Y (NPY) Y1 受体拮抗剂，对人和大鼠 Y1 受体均具有高亲和力 (IC50 分别为 0.38 和 0.72 nM)。体内研究
BIBO3304 TFA (30 μg; bilateral paraventricular nucleus injection) attenuates the hyperphagia following fasting.
BIBO3304 TFA (15-60 μg) dose-dependently inhibits the feeding reponse mediated by 1 μg NPY.
BIBO3304 TFA (0.5 μM; p.o.) significantly increases serum insulin levels.
| Animal Model: | Adult male Chbb:Thom rats weighing between 300 and 340 g |
| Dosage: | 30 μg |
| Administration: | bilateral paraventricular nucleus injection |
| Result: | Attenuated the hyperphagia following fasting, especially during the first 2 h of refeeding. |
| Animal Model: | 7-week-old C57BL/6JAusb mice |
| Dosage: | 0.5 μM |
| Administration: | p.o. |
| Result: | Significantly increased serum insulin levels. |